Analyst Price Target is GBX 5,120
▲ +86.32% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Genus in the last 3 months. The average price target is GBX 5,120, with a high forecast of GBX 5,740 and a low forecast of GBX 4,500. The average price target represents a 86.32% upside from the last price of GBX 2,748.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in Genus. This Buy consensus rating has held steady for over two years.
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.